Postmarketing Surveillance of Prescription Drugs
Description:
A report by the Office of Technology Assessment (OTA) that "describes the drug approval process, the history and objectives of post-marketing surveillance, the methods employed to accomplish it, and current activities in postmarketing surveillance" (p. iii).
Date:
November 1982
Creator:
United States. Congress. Office of Technology Assessment.
Item Type:
Refine your search to only
Report
Partner:
UNT Libraries Government Documents Department